(Circulation. 1999;100:2184.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
From the Department of Cardiology, University of Heidelberg (A. Bauer, R.B., K.D.F., J.C.S., F.V., A.H., M.M., P.K., W.K., W.S.), and Hoechst Marion Roussel, Cardiovascular Pharmacology, Frankfurt (H.J.L., U.G., A. Busch), Germany.
Correspondence to Dr Alexander Bauer, Abteilung Innere Medizin III, Medizinische Universitätsklinik, Bergheimerstraße 58, 69115 Heidelberg, Germany. E-mail alexander_bauer{at}med.uni-heidelberg.de
BackgroundRecent in vitro studies have demonstrated regional differences in electrophysiological properties of individual left ventricular muscle layers. Controversy exists on the relevance of these findings for the situation in vivo. Thus, this study was designed to determine whether the in vivo canine heart exhibits regional differences in left ventricular refractoriness and in the susceptibility to sodium and potassium channel blockers.
Methods and ResultsIn 16 dogs, 36 needle electrodes (12 mm long, 4 bipolar electrodes, interelectrode distance 2.5 mm) were inserted into the left ventricular wall. By use of a computerized multiplexer-mapping system, the spread of activation in epicardial, endocardial, and midmyocardial muscle was reconstructed during ventricular pacing at 300- and 850-ms basic cycle length (BCL). Effective refractory periods (ERPs) were determined at baseline and after application of propafenone (2 mg/kg), dofetilide (30 µg/kg), or chromanol 293b (10 mg/kg) by the extrastimulus technique (BCL 300 and 850 ms). At baseline, activation patterns and ERPs were uniform in all muscle layers. Propafenone homogeneously decreased conduction velocity and moderately prolonged ERPs without any regional differences. Dofetilide and chromanol 293b did not affect the spread of activation. Dofetilide exhibited reverse use-dependent effects on ERP, still preserving transmural homogeneity of refractoriness. Chromanol 293b led to a regionally uniform but more pronounced increase in local ERPs at faster than at slower pacing rates.
ConclusionsAt the heart rates applied, the in vivo canine heart does not exhibit regional differences in electrophysiological properties. Given the homogeneity of antiarrhythmic drug effects, induction of local gradients of refractoriness is obviously not a common mechanism of proarrhythmia in normal hearts.
Key Words: antiarrhythmia agents arrhythmia electrophysiology mapping
This article has been cited by other articles:
![]() |
M. J. Janse, E. A. Sosunov, R. Coronel, T. Opthof, E. P. Anyukhovsky, J. M.T. de Bakker, A. N. Plotnikov, I. N. Shlapakova, P. Danilo Jr, J. G.P. Tijssen, et al. Repolarization Gradients in the Canine Left Ventricle Before and After Induction of Short-Term Cardiac Memory Circulation, September 20, 2005; 112(12): 1711 - 1718. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E Conrath, R. Wilders, R. Coronel, J. M.T de Bakker, P. Taggart, J. R de Groot, and T. Opthof Intercellular coupling through gap junctions masks M cells in the human heart Cardiovasc Res, May 1, 2004; 62(2): 407 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G.A. Volders, M. Stengl, J. M. van Opstal, U. Gerlach, R. L.H.M.G. Spatjens, J. D.M. Beekman, K. R. Sipido, and M. A. Vos Probing the Contribution of IKs to Canine Ventricular Repolarization: Key Role for {beta}-Adrenergic Receptor Stimulation Circulation, June 3, 2003; 107(21): 2753 - 2760. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lynch Jr., J. J. Salata, A. A. Wallace, G. L. Stump, D. B. Gilberto, H. Jahansouz, N. J. Liverton, H. G. Selnick, and D. A. Claremon Antiarrhythmic Efficacy of Combined IKs and beta -Adrenergic Receptor Blockade J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 283 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Transmural dispersion of repolarization and the T wave Cardiovasc Res, June 1, 2001; 50(3): 426 - 431. [Full Text] [PDF] |
||||
![]() |
P. Taggart, P. M.I Sutton, T. Opthof, R. Coronel, R. Trimlett, W. Pugsley, and P. Kallis Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia Cardiovasc Res, June 1, 2001; 50(3): 454 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Doshi and B. N. Singh Reviews: Pure Class III Antiarrhythmic Drugs: Focus on Dofetilide Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 237 - 247. [PDF] |
||||
![]() |
P. Dorian and D. Newman Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview Europace, January 1, 2000; 2(4): 277 - 285. [Abstract] [PDF] |
||||
![]() |
D. O. Kozhevnikov, K. Yamamoto, D. Robotis, M. Restivo, and N. El-Sherif Electrophysiological Mechanism of Enhanced Susceptibility of Hypertrophied Heart to Acquired Torsade de Pointes Arrhythmias: Tridimensional Mapping of Activation and Recovery Patterns Circulation, March 5, 2002; 105(9): 1128 - 1134. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |